Ameritas Investment Partners, Inc. Syros Pharmaceuticals, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.69 - $1.21 $2,530 - $4,437	-3,667 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$5.21 - $11.03 $5,548 - $11,746	1,065 Added 40.93%	3,667 $39,000
Q2 2018 Aug 13, 2018	BUY	$10.16 - $13.65 $15,280 - $20,529	1,504 Added 136.98%	2,602 $27,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,098	1,098 $18,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.